← brief for 2026-08-14 · Slowing decline

Impact of Angiotensin Receptor-Neprilysin Inhibition Combined with Enteral Nutritional Therapy on Cardiac Performance and Inflammatory Burden in Hemodialysis-Associated Heart Failure: Clinical and Experimental Evidence.

Article B Peer reviewed Small trial

Key takeaways

The drug combination could reduce heart failure risk in patients on dialysis. The study used 35 patients for 6 months. This could help prevent heart failure in dialysis patients.

Who did this work

Liu X · Lu T · Hu Q · Yang C

Source

Article · PubMed, CKD progression · 2026 Jul 22
https://pubmed.ncbi.nlm.nih.gov/42597327/